SODIUM CITRATE, UNSPECIFIED FORM
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 189.0 | -5.3 | 1 | 7 | 141.0 | 5 | 0.5 |
- UNII
- 1Q73Q2JULR
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| An,infiltration | Injection | 0.04% |
| Auricular (Otic) | Solution | 2% |
| Auricular (Otic) | Suspension | |
| Epidural | Injection | 2.2% |
| Im - Iv | Injectable | 1.35% |
| Im - Iv | Injection | 40% |
| Im - Iv | Solution | 0.03% |
| Im - Iv - Sc | Injection | 0.94% |
| Im - Sc | Injection | 0.23% |
| Inhalation | Inhalant | |
| Intra-Arterial | Injection | |
| Intra-Articular | Injection | 2.2% |
| Intracardiac | Injection | 0.8% |
| Intracavitary | Injection | 0.15% |
| Intracavitary | Powder, For Injection Solution, Lyophilized | 0.01% |
| Intralesional | Injection | 1% |
| Intramuscular | Injectable | 0.62% |
| Intramuscular | Injection | 4% |
| Intramuscular | Powder, For Injection Solution | 4.62% |
| Intramuscular | Powder, For Injection Solution, Lyophilized | 0.65% |
| Intramuscular | Solution, Injection | 2.14% |
| Intraocular | Solution | 0.4% |
| Intraperitoneal | Injection | 2.2% |
| Intrapleural | Injection | |
| Intrapleural | Powder, For Injection Solution | 4.62% |
| Intrasynovial | Injection | 1% |
| Intrathecal | Injection | |
| Intrathecal | Powder, For Injection Solution | 4.62% |
| Intratracheal | Suspension | |
| Intrauterine | Solution | |
| Intravascular | Injection | 0.32% |
| Intravenous | Infusion | |
| Intravenous | Injectable | |
| Intravenous | Injection | 30% |
| Intravenous | Powder, For Injection Solution | 0.16% |
| Intravenous | Powder, For Injection Solution, Lyophilized | 16.35% |
| Intravenous | Solution | 0.83% |
| Intravenous | Solution, Injection | 0.07% |
| Iontophoresis | Drug Delivery System | 2.2MG |
| Irrigation | Injection | 1.1% |
| Iv(Infusion) | Injectable | 3% |
| Iv(Infusion) | Injection | 40% |
| Iv(Infusion) | Powder, For Injection Solution | 8% |
| Iv(Infusion) | Powder, For Injection Solution, Lyophilized | 14% |
| Iv(Infusion) | Solution, Concentrate | 0.48% |
| Iv(Infusion) | Solution, Injection | 0.6% |
| Nasal | Gel | |
| Nasal | Solution | 70% |
| Nasal | Spray | 0.44% |
| Nasal | Spray, Metered | 0.07%W/V |
| Nerve Block | Injection | 0.04% |
| Ophthalmic | Powder, For Solution | 0.17% |
| Ophthalmic | Solution | 2.2% |
| Ophthalmic | Solution, Drops | 2% |
| Ophthalmic | Suspension | 0.3% |
| Ophthalmic | Suspension, Drops | 0.45% |
| Oral | Concentrate | 0.51% |
| Oral | Drops | 2% |
| Oral | Emulsion | |
| Oral | Granule | 210.63MG |
| Oral | Granule, For Reconstitution | 0.7MG |
| Oral | Granule, For Suspension | 15MG |
| Oral | Liquid | 1.2% |
| Oral | Powder, For Oral Suspension | 0.8% |
| Oral | Powder, For Reconstitution | 0.04% |
| Oral | Powder, For Solution | |
| Oral | Solution | 2.09% |
| Oral | Solution, Concentrate | 0.05% |
| Oral | Solution, Elixir | 0.45% |
| Oral | Solution, Liquid | 0.71% |
| Oral | Suspension, For Inhalation | 0.05% |
| Oral | Suspension, Liquid | 0.1% |
| Oral | Suspension, Sustained Action | 2.35% |
| Oral | Syrup | 25MG |
| Oral | Tablet | 275MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 300MG |
| Oral | Tablet, Coated | 19MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 82MG |
| Oral | Tablet, Extended Release | 71.88MG |
| Oral | Tablet, Film Coated | 200MG |
| Oral-28 | Tablet | |
| Rectal | Solution | |
| Respiratory (Inhalation) | Powder, For Inhalation | 0.14% |
| See Dosage Form | Injection | 0.03% |
| Soft Tissue | Injection | 1% |
| Subcutaneous | Powder, For Injection Solution, Lyophilized | 0.65% |
| Subcutaneous | Solution, Injection | 2.14% |
| Sublingual | Tablet | 17MG |
| Sublingual | Tablet (Immed./comp. Release), Uncoated, Buccal | 3.52MG |
| Topical | Emulsion, Cream | 0.25% |
| Topical | Emulsion, Lotion | 0.08% |
| Topical | Lotion | 0.08%W/W |
| Topical | Shampoo | 2.6% |
| Topical | Solution | 0.1%W/V |
| Topical | Solution, Drops | 0.29%W/V |
| Transdermal | Drug Delivery System | 2.2MG |
| Ureteral | Solution | |
| Vaginal | Sponge | 7.6MG |